We previously reported significant elevation of pathway genes TET1, TARDBP, and SRSF2 in TNBC tumor samples obtained from obese (BMI > 30) compared to non-obese (BMI < 30) patients, as measured by qRT-PCR [32]. The gene discussed is TARDBP; the disease is neoplasm.